Novel Insights into the Inhibitory Mechanism of Kaempferol on Xanthine Oxidase
Citations Over TimeTop 10% of 2014 papers
Abstract
Xanthine oxidase (XO), a key enzyme in purine catabolism, is widely distributed in human tissues. It can catalyze xanthine to generate uric acid and cause hyperuricemia and gout. Inhibition kinetics assay showed that kaempferol inhibited XO activity reversibly in a competitive manner. Strong fluorescence quenching and conformational changes of XO were found due to the formation of a kaempferol-XO complex, which was driven mainly by hydrophobic forces. The molecular docking further revealed that kaempferol inserted into the hydrophobic cavity of XO to interact with some amino acid residues. The main inhibition mechanism of kaempferol on XO activity may be due to the insertion of kaempferol into the active site of XO occupying the catalytic center of the enzyme to avoid the entrance of the substrate and inducing conformational changes of XO. In addition, luteolin exhibited a stronger synergistic effect with kaempferol than did morin at the lower concentration.
Related Papers
- → Crystalline Deposits in Striped Muscle in Xanthinuria(1969)25 cited
- Inhibition of xanthine oxidase by hydroxylated anthraquinones and related compounds.(1998)
- → Dinuclear Cyclam Complex as a Non-Cytotoxic, Anti-Hyperurecemic Lead: In vitro to In vivo Studies(2017)4 cited
- Regulating Effect of Modified Yinchen Wuling Powder on Xanthine Oxidase Activity in Rats with Hyperuricemia(2010)
- Research on the effect of FRUCTUS GARDENIAE extract on reducing uric acid in hyperuricemia mice and its action mechanism.(2012)